Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
ATMPs via the European Medicines Agency: https://www.ema.europa.eu/en/human-regulatory-overview/advanced-therapy-medicinal-products-overview If you are curious, internationally minded, and driven by a
-
. The position is embedded in a broader research agenda on trustworthy, data-driven software engineering and AI-assisted development. The successful candidate will work on Bug Report Intelligence
-
development support. Qualifications Specific Requirements MSc in Pharmacy; Experience with amino acid transporters; Experience with pharmaceutical application of drug transporters; Strong motivation and
-
. Benefits and salary The successful candidates will receive an attractive salary in accordance with the MSCA regulations for Early-Stage Researchers (http://ec.europa.eu/research/mariecurieactions
-
publication-based PhD qualification, including: - Review of previous literature and the relevant theoretical background - Analysis of existing/secondary survey dataset(s) - Development of new survey and
-
bioprocess optimization. The successful candidate will contribute to the development of sustainable bioconversion platforms for the transformation of biogas-derived carbon into amino acid-enriched biomass
-
DTU Tenure Track Researcher on Nanoreactors for Operando Visualizations of Nanoparticle Catalysis...
microscopy for nanoparticle catalysis at the Center for Visualizing Catalytic Processes (VISION). Responsibilities and qualifications You will engage with VISION’s development and application of nanoreactors
-
on the evolution of gene regulatory networks and Wnt pathway functions in emerging model organisms (e. g. insects, annelids, snails, flatworms, cnidarians), utilizing ‘omics technologies and bioinformatics. Students
-
well as multifold training and support for PhD students in framework of ISAS and the Leibniz association Training and scientific development opportunities in an international environment and an excellent working
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient